AtriCure (ATRC) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 18

7 insiders sold $2.7M. No buys.

SellRegina E. Groves$288KDirectorat $54.22 on Sep 11, filed Sep 14

SellRegina E. GrovesDirector$288Kat $54.22 on Sep 11, filed Sep 14

SellKarl S. Dahlquist$458KChief Legal Officerat $48.89 on Aug 24, filed Aug 26

SellKarl S. DahlquistChief Legal Officer$458Kat $48.89 on Aug 24, filed Aug 26

SellKaren Prange$138KDirectorat $38.80 on Aug 5, filed Aug 7

SellKaren PrangeDirector$138Kat $38.80 on Aug 5, filed Aug 7

From SEC Form 4s, the newest filed Sep 14, 2026 · Insiders have 2 business days to file a trade

6 more filings on ATRC in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 9 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ATRC with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at AtriCure

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ATRC's insider trades

As of Nov 2, 2026: AtriCure (ATRC) has 9 insider filings on record in the last 6 months, the newest filed Sep 14, 2026. Its Quality Score is 18 (Excellent). Scores as of 5:08 PM ET, 15 minutes behind.

Are ATRC insiders buying or selling?

7 insiders sold $2.7M across 9 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Regina E. Groves, Director, sold $288K on Sep 11, 2026.

Who are ATRC's biggest insider sellers?

By the dollars of their sales in the last 6 months: Sven Wehrwein (Director), 1 sale; Karl S. Dahlquist (Chief Legal Officer), 1 sale; Vinayak Doraiswamy (Chief Scientific Officer), 2 sales. 7 insiders sold in all.

When did an ATRC insider last buy?

No ATRC insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Regina E. Groves on Sep 11, 2026.

AtriCure's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices.